Home › Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers
 

Keywords :   


Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers

2013-09-17 08:07:34| Biotech - Topix.net

The FDA granted approval to a generic version of Xeloda, produced by Teva Pharmaceutical, for the treatment of metastatic colorectal and breast cancers.

Tags: version approval generic gains

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.11BG
26.11 DVD 9
26.11Happy2024 LAST BIG
26.111-21
26.11A-68507
26.11160cm
26.11stray kids GO yes24
26.11 mark borthwick whats bummer zine edition
More »